Infographic showing the progression of Xtandi from publicly funded research at UCLA to

Infographic showing the progression of Xtandi from publicly funded research at UCLA to a drug sold for $180,000 a year.

This infographic humorously critiques how publicly funded research at UCLA led to Xtandi, a drug now priced at $180,000 annually, spotlighting the irony of taxpayer-funded science fueling lucrative private profits.